Dostawa produktów leczniczych stosowanych w programach lekowych i chemioterapii nowotworów na potrzeby Klinik USK-2 PUM w Szczecinie
5 suppliers awarded•14 lots awarded•€430,315 awarded
Buyer: UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE / Szczecin, Poland
Awarded value
€430.3K
Estimated value
€590.6K
Awarded at 73% of estimated value
Award date
Aug 06, 2026
Winners
5
Lots awarded
14
Award values
Notice total
€430.3K
Sum of lot awards
€439.3K
TED notice total and lot-level values do not exactly match.
Winners
WARSZAWA, POL
€201,801 This contract
9 award notices•13 awarded lots•€716,144 total
Wrocław, POL
€69,003 This contract
161 award notices•422 awarded lots•€248.50M total
wrocława, POL
€65,004 This contract
89 award notices•281 awarded lots•€8.54M total
KATOWICE, POL
€60,360 This contract
79 award notices•237 awarded lots•€15.20M total
warszawa, POL
€787 This contract
15 award notices•47 awarded lots•€1.94M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0004 | BAXTER POLSKA SP. Z O.O. | €184,565 | Antineoplastic agents (33652100) | |
| LOT-0005 | "ASCLEPIOS" SPÓŁKA AKCYJNA | €53,593 | Antineoplastic agents (33652100) | |
| LOT-0014 | Not specified | €42,368 | Antineoplastic agents (33652100) | |
| LOT-0007 | URTICA Sp.zo.o. | €32,264 | Antineoplastic agents (33652100) | |
| LOT-0008 | SALUS INTERNATIONAL SP. Z O.O. | €32,264 | Antineoplastic agents (33652100) | |
| LOT-0002 | URTICA Sp.zo.o. | €17,331 | Antineoplastic agents (33652100) | |
| LOT-0010 | BAXTER POLSKA SP. Z O.O. | €17,236 | Antineoplastic agents (33652100) | |
| LOT-0012 | SALUS INTERNATIONAL SP. Z O.O. | €14,801 | Antineoplastic agents (33652100) | |
| LOT-0006 | SALUS INTERNATIONAL SP. Z O.O. | €13,295 | Antineoplastic agents (33652100) | |
| LOT-0011 | URTICA Sp.zo.o. | €12,058 | Antineoplastic agents (33652100) | |
| LOT-0003 | "ASCLEPIOS" SPÓŁKA AKCYJNA | €8,250 | Antineoplastic agents (33652100) | |
| LOT-0009 | URTICA Sp.zo.o. | €7,350 | Antineoplastic agents (33652100) | |
| LOT-0013 | "ASCLEPIOS" SPÓŁKA AKCYJNA | €3,161 | Antineoplastic agents (33652100) | |
| LOT-0001 | "FRESENIUS KABI POLSKA" sp. z o.o. | €787 | Medicinal products for the genitourinary system and sex hormones (33641000) |